LOGIN  |  REGISTER

Recent Insider Transactions - Cue Biopharma (NASDAQ: CUE)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CUE Cue Biopharma
Sandercock Colin / officer: SVP, GENERAL COUNSEL
03/06/2024
Buy
$1.94
175,000
$340K
175,000
NASDAQ CUE Cue Biopharma
Suri Anish / officer: PRESIDENT AND CSO
03/06/2024
Buy
$1.94
300,000
$582K
300,000
NASDAQ CUE Cue Biopharma
Millar Kerri-Ann / officer: CHIEF FINANCIAL OFFICER
03/06/2024
Buy
$1.94
250,000
$485K
250,000
NASDAQ CUE Cue Biopharma
PASSERI DANIEL R / director, officer: CHIEF EXECUTIVE OFFICER
03/06/2024
Buy
$1.94
400,000
$776K
400,000
NASDAQ CUE Cue Biopharma
Levisetti Matteo / officer: Chief Medical Officer
03/06/2024
Buy
$1.94
260,000
$504K
260,000
NASDAQ CUE Cue Biopharma
Levisetti Matteo / officer: Chief Medical Officer
02/20/2024
Buy
$3.36
25,000
$84K
25,000
NASDAQ CUE Cue Biopharma
Garzone Pamela / director
01/02/2024
Buy
$2.78
24,400
$68K
24,400
NASDAQ CUE Cue Biopharma
Kiener Peter A / director
01/02/2024
Buy
$2.78
24,400
$68K
24,400
NASDAQ CUE Cue Biopharma
DRISCOLL FREDERICK W / director
01/02/2024
Buy
$2.78
24,400
$68K
24,400
NASDAQ CUE Cue Biopharma
Verheyen Patrick / director
01/02/2024
Buy
$2.78
24,400
$68K
24,400
NASDAQ CUE Cue Biopharma
Morich Frank / director
01/02/2024
Buy
$2.78
24,400
$68K
24,400
NASDAQ CUE Cue Biopharma
Suri Anish / officer: PRESIDENT AND CSO
08/25/2023
Buy
$2.76
4,000
$11K
135,638
NASDAQ CUE Cue Biopharma
PASSERI DANIEL R / director, officer: CHIEF EXECUTIVE OFFICER
08/14/2023
Buy
$2.86
3,000
$9K
134,578
NASDAQ CUE Cue Biopharma
Levisetti Matteo / officer: Chief Medical Officer
07/21/2023
Buy
$4.20
82,500
$347K
82,500
NASDAQ CUE Cue Biopharma
Millar Kerri-Ann / officer: CHIEF FINANCIAL OFFICER
07/21/2023
Buy
$4.20
113,000
$475K
113,000
NASDAQ CUE Cue Biopharma
PASSERI DANIEL R / director, officer: CHIEF EXECUTIVE OFFICER
07/21/2023
Buy
$4.20
450,000
$1.890M
450,000
NASDAQ CUE Cue Biopharma
Sandercock Colin / officer: SVP, GENERAL COUNSEL
07/21/2023
Buy
$4.20
75,000
$315K
75,000
NASDAQ CUE Cue Biopharma
Suri Anish / officer: PRESIDENT AND CSO
07/21/2023
Buy
$4.20
124,125
$521K
124,125
NASDAQ CUE Cue Biopharma
Garzone Pamela / director
04/19/2023
Buy
$3.46
40,000
$138K
40,000
NASDAQ CUE Cue Biopharma
Verheyen Patrick / director
04/11/2023
Buy
$3.11
40,000
$124K
40,000
NASDAQ CUE Cue Biopharma
Kiener Peter A / director
03/23/2023
Sell
$2.86
9,682
$28K
96,062
NASDAQ CUE Cue Biopharma
Kiener Peter A / director
03/23/2023
Buy
$2.86
9,682
$28K
9,682
NASDAQ CUE Cue Biopharma
Kiener Peter A / director
03/23/2023
Sell
$3.28
9,325
$31K
357
NASDAQ CUE Cue Biopharma
NASSHORN PATRICIA / officer: Chief Business Officer
02/16/2023
Buy
$3.21
97,900
$314K
97,900
NASDAQ CUE Cue Biopharma
Suri Anish / officer: PRESIDENT AND CSO
02/16/2023
Buy
$3.21
125,500
$403K
125,500
NASDAQ CUE Cue Biopharma
Sandercock Colin / officer: SVP, GENERAL COUNSEL
02/16/2023
Buy
$3.21
100,000
$321K
100,000
NASDAQ CUE Cue Biopharma
PASSERI DANIEL R / director, officer: CHIEF EXECUTIVE OFFICER
02/16/2023
Buy
$3.21
324,000
$1.040M
324,000
NASDAQ CUE Cue Biopharma
Millar Kerri-Ann / officer: CHIEF FINANCIAL OFFICER
02/16/2023
Buy
$3.21
124,000
$398K
124,000
NASDAQ CUE Cue Biopharma
Levisetti Matteo / officer: Chief Medical Officer
01/17/2023
Sell
$5.01
10,000
$50K
0
NASDAQ CUE Cue Biopharma
Millar Kerri-Ann / officer: CHIEF FINANCIAL OFFICER
08/21/2022
Sell
$3.05
2,828
$9K
14,311
NASDAQ CUE Cue Biopharma
Gray Cameron / director:
06/14/2022
Buy
$2.70
61,111
$165K
738,611
NASDAQ CUE Cue Biopharma
Gray Cameron / director:
06/14/2022
Sell
$3.20
51,562
$165K
687,049
NASDAQ CUE Cue Biopharma
Gray Cameron / director
06/14/2022
Sell
$2.70
61,111
$165K
0
NASDAQ CUE Cue Biopharma
Morich Frank / director:
05/27/2022
Buy
$3.75
28,000
$105K
28,000
NASDAQ CUE Cue Biopharma
Fletcher Aaron G.L. / director:
05/23/2022
Buy
$3.34
55,000
$184K
940,000
NASDAQ CUE Cue Biopharma
Fletcher Aaron G.L. / director
05/23/2022
Buy
$3.52
150,000
$528K
885,000

COPYRIGHT ©2023 HEALTH STOCKS HUB